Quest 10 Wealth Builders, Inc. Astrazeneca PLC Transaction History
Quest 10 Wealth Builders, Inc.
- $93.4 Billion
- Q1 2025
A detailed history of Quest 10 Wealth Builders, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Quest 10 Wealth Builders, Inc. holds 123 shares of AZN stock, worth $8,835. This represents 0.01% of its overall portfolio holdings.
Number of Shares
123
Previous 123
-0.0%
Holding current value
$8,835
Previous $8.06 Million
12.19%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
507MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.1 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.29 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.25 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...